Adam Stenman

发表

Whole‐exome sequencing defines the mutational landscape of pheochromocytoma and identifies KMT2D as a recurrently mutated gene

Jenny Welander, Gerald Goh, Stefano Caramuta, 2015, Genes, chromosomes & cancer.

Immunohistochemical NF1 Analysis Does not Predict NF1 Gene Mutation Status in Pheochromocytoma

P. Söderkvist, A. Stenman, O. Gimm, 2015, Endocrine Pathology.

Aberrant splicing in neuroblastoma generates RNA-fusion transcripts and provides vulnerability to spliceosome inhibitors

C. Larsson, M. O'sullivan, O. Bedoya-Reina, 2021, Nucleic acids research.

Splicing-sensitive fusion transcripts associated with key tumor characteristics occur at high frequency in neuroblastoma

C. Larsson, M. O'sullivan, A. Stenman, 2019, bioRxiv.

Alternative splicing in neuroblastoma generates RNA-fusion transcripts and is associated with vulnerability to spliceosome inhibitors

C. Larsson, M. O'sullivan, O. Bedoya-Reina, 2019 .

Genetic and molecular background of pheochromocytoma and paraganglioma

A. Stenman, Adam Stenman, 2015 .

HRAS mutation prevalence and associated expression patterns in pheochromocytoma

C. Larsson, M. Bäckdahl, P. Söderkvist, 2016, Genes, chromosomes & cancer.

Adrenal and periadrenal schwannoma: histological, molecular and clinical characterization of an institutional case series.

H. Falhammar, J. Zedenius, C. Juhlin, 2023, Endocrine.

Metastatic Anaplastic Thyroid Carcinoma in Complete Remission: Morphological, Molecular, and Clinical Work-Up of a Rare Case

A. Stenman, K. Jatta, J. Zedenius, 2020, Endocrine Pathology.

Whole‐genome sequencing of synchronous thyroid carcinomas identifies aberrant DNA repair in thyroid cancer dedifferentiation

A. Stenman, N. Wang, J. Zedenius, 2020, The Journal of pathology.

Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing.

S. Mane, C. Larsson, D. Rimm, 2015, Human molecular genetics.

Synchronous aldosterone- and cortisol-producing adrenocortical adenomas diagnosed using CYP11B immunohistochemistry

A. Stenman, J. Zedenius, I. Shabo, 2019, SAGE open medical case reports.

Suppression of Forkhead Box Protein O1 (FOXO1) Transcription Factor May Promote Adrenocortical Tumorigenesis

A. Stenman, Timothy D. Murtha, R. Korah, 2017, Hormone and Metabolic Research.

A novel FOXO1-mediated dedifferentiation blocking role for DKK3 in adrenocortical carcinogenesis

C. Larsson, U. Scholl, W. Knoefel, 2017, BMC Cancer.

Development of metastatic poorly differentiated thyroid cancer from a sub-centimeter papillary thyroid carcinoma in a young patient with a germline MET mutation – association or random chance?

A. Stenman, J. Zedenius, Johan O Paulsson, 2021, Thyroid Research.

Seasonal variation in calcium treatment after thyroidectomy as surrogate for post-operative hypocalcemia: a retrospective register-based national cohort study

A. Stenman, R. Bränström, A. Koman, 2022, Thyroid Research.

Clinical Characterization of the Pheochromocytoma and Paraganglioma Susceptibility Genes SDHA, TMEM127, MAX, and SDHAF2 for Gene-Informed Prevention

C. Larsson, C. Eng, P. Söderkvist, 2017, JAMA oncology.

Retrospective application of the pathologic tumor-node-metastasis classification system for pheochromocytoma and abdominal paraganglioma in a well characterized cohort with long-term follow-up.

A. Stenman, J. Zedenius, C. Juhlin, 2019, Surgery.

The Value of Histological Algorithms to Predict the Malignancy Potential of Pheochromocytomas and Abdominal Paragangliomas—A Meta-Analysis and Systematic Review of the Literature

A. Stenman, J. Zedenius, C. Juhlin, 2019, Cancers.

Whole-exome sequencing characterizes the landscape of somatic mutations and copy number alterations in adrenocortical carcinoma.

Annabelle L. Fonseca, S. Mane, C. Larsson, 2015, The Journal of clinical endocrinology and metabolism.

Pan-Genomic Sequencing Reveals Actionable CDKN2A/2B Deletions and Kataegis in Anaplastic Thyroid Carcinoma

A. Stenman, Minjun Yang, J. Zedenius, 2021, Cancers.

Macrofollicular variant follicular thyroid tumors are DICER1 mutated and exhibit distinct histological features

A. Stenman, J. Zedenius, C. Juhlin, 2021, Histopathology.

Atrophic changes in thyroid tumors are strong indicators of underlying DICER1 mutations: a bi-institutional genotype-phenotype correlation study.

C. Juhlin, K. Viswanathan, Catharina Larsson, 2024, Virchows Archiv.

DNA copy amplification and overexpression of SLC12A7 in adrenocortical carcinoma.

R. Korah, T. Carling, J. Rubinstein, 2016, Surgery.

Digital droplet PCR TERT promoter mutational screening in fine needle aspiration cytology of thyroid lesions: A highly specific technique for pre‐operative identification of high‐risk cases

C. Larsson, A. Stenman, K. Jatta, 2023, Diagnostic cytopathology.

Nuclear-specific accumulation of telomerase reverse transcriptase (TERT) mRNA in TERT promoter mutated follicular thyroid tumours visualised by in situ hybridisation: a possible clinical screening tool?

C. Larsson, A. Stenman, J. Zedenius, 2021, Journal of Clinical Pathology.

Clinical Routine TERT Promoter Mutational Screening of Follicular Thyroid Tumors of Uncertain Malignant Potential (FT-UMPs): A Useful Predictor of Metastatic Disease

C. Larsson, A. Stenman, K. Jatta, 2019, Cancers.

GABPA inhibits invasion/metastasis in papillary thyroid carcinoma by regulating DICER1 expression

C. Larsson, A. Stenman, Dawei Xu, 2018, Oncogene.

TERT promoter mutations are rare in parathyroid tumors.

C. Larsson, M. Prasad, R. Korah, 2015, Endocrine-related cancer.

Metastatic-prone telomerase reverse transcriptase (TERT) promoter and v-Raf murine sarcoma viral oncogene homolog B (BRAF) mutated tall cell variant of papillary thyroid carcinoma arising in ectopic thyroid tissue

A. Stenman, C. Juhlin, C. Ihre-Lundgren, 2021, Medicine.

Absence of the BRAF V600E mutation in pheochromocytoma

P. Söderkvist, C. Juhlin, A. Stenman, 2016, Journal of Endocrinological Investigation.

Prognostic Utility of the Ki-67 Labeling Index in Follicular Thyroid Tumors: a 20-Year Experience from a Tertiary Thyroid Center

C. Larsson, A. Stenman, J. Zedenius, 2022, Endocrine Pathology.

Novel Insights in the Genomics of Anaplastic Thyroid Carcinoma: A Role for Cyclin-Dependent Kinase Inhibition?

A. Stenman, C. Juhlin, Adam Stenman, 2023, Cancers.